Publisher Mary Ann Liebert, Inc., publishers has announced that Dr. Mark A. Kay, a long-time Associate Editor of the Human Gene Therapy journal, will assume the position of Editor, effective immediately. Dr. James Wilson will continue as Editor-in-Chief of the Human Gene Therapy publishing program, including Human Gene Therapy, Human Gene Therapy Methods, and Human Gene Therapy Clinical Development, published by Mary Ann Liebert, Inc., publishers.
Dr. Kay is Head of the Division of Human Gene Therapy and the Dennis Farrey Family Professor in the Departments of Pediatrics and Genetics at Stanford University. He has published over 200 scientific papers.
Human Gene Therapy is the official journal of the European Society of Gene and Cell Therapy, British Society for Gene and Cell Therapy, French Society of Cell and Gene Therapy, German Society of Gene Therapy, and five other gene therapy societies. An authoritative peer-reviewed journal published monthly in print and online, Human Gene Therapy presents reports on the transfer and expression of genes in mammals, including humans. Related topics include improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, as well as ethical, legal, and regulatory issues related to the gene transfer in humans.
